Europe Acne Medication Market Forecast to 2030 - Regional Analysis - by Therapeutic Class, Formulation, Type, Acne Type, and Distribution Channel

List of Tables

The Europe acne medication market was valued at US$ 1,963.08 million in 2022 and is expected to reach US$ 3,112.69 million by 2030; it is estimated to register at a CAGR of 6.0% from 2023 to 2030.

Individualized Treatment Programs Based on Cutting-Edge Technologies and Data-Driven Strategies Drive Europe Acne Medication Market

Adopting advanced technologies and data-driven approaches in the Europe acne medication market opens up new avenues for research and development. By collecting and analyzing patient data, researchers can gain valuable insights into the underlying causes of acne, identify patterns and trends in treatment responses, and discover new potential targets for therapeutic interventions. This can drive the development of novel medications, innovative treatment strategies, and more personalized skincare products tailored to the diverse needs of acne patients. By leveraging artificial intelligence (AI), machine learning algorithms, genetic testing, and other cutting-edge tools, healthcare providers can now analyze vast data to gain a better understanding of patient's unique skin conditions, genetic predispositions, lifestyle factors, and treatment responses. This personalized approach allows for the development of tailored treatment plans specifically designed to address each patient's individual needs.

In March 2021, Onegevity, a health intelligence firm and a subsidiary of Thorne HealthTech, teamed up with Unilever, one of the top manufacturers of beauty and personal care products worldwide, to enable a more personalized approach to acne intervention and treatment. The scientific collaboration is meant to investigate the potential of multi-omics, or the integration of different biological disciplines, to enable more individualized approaches to treating acne. The collaboration aims to create new diagnostic models that can unlock customized acne treatment plans by utilizing Onegevity's AI and machine learning capabilities that allow the evaluation of billions of biological characteristics affecting a person's health. Personalized treatment plans help to optimize treatment efficacy by taking into account patients' specific characteristics and factors that may influence their response to acne medication. Based on such patient-specific data, healthcare providers can prescribe treatments that are more likely to be effective for that particular individual. This improves the chances of successfully treating acne and reduces the likelihood of side effects and adverse reactions, leading to better patient outcomes and increased satisfaction. Thus, integrating advanced technologies and data-driven approaches for designing personalized treatment plans creates significant opportunities for innovation, growth, and improved patient outcomes in the Europe acne medication market.

Europe Acne Medication Market Overview

Europe ranks second in the global acne medication market. It is further anticipated to register a significant CAGR during the forecast period. The acne medication market growth in the region is ascribed to the increasing prevalence of acne and the growing presence of major players. The research-based pharmaceutical industry can play a key role in supporting the acne medication market growth in Europe and ensuring its future competitiveness in the global economy. Formel Skin, a Berlin-based business that is a pioneer in dermatology telehealth, announced the completion of a US$ 32.35 (30) million series fundraising round in January 2022. The funding was led by Singular and Heal Capital and supported by Cherry Ventures, Heartcore Capital, and Vorwerk Ventures. With this funding, the company plans to undertake the long-term development and expansion of its remote skincare platform.

Europe Acne Medication Market Revenue and Forecast to 2030 (US$ Million)

Europe Acne Medication Market Segmentation

The Europe acne medication market is segmented based on therapeutic class, formulation, type, acne type, distribution channel, and country.

Based on therapeutic class, the Europe acne medication market is segmented into retinoids, benzoyl peroxide, antibiotics, salicylic acid, and others. The retinoids segment held the largest share in 2022.

In terms of formulation, the Europe acne medication market is bifurcated into topical medication and oral medication. The topical medication segment held a larger largest share in 2022.

By type, the Europe acne medication market is bifurcated into prescription medicine and over-the-counter medicine. The prescription medicine segment held a larger largest share in 2022.

Based on acne type, the Europe acne medication market is bifurcated into non-inflammatory acne and inflammatory acne. The inflammatory acne segment held a larger share in 2022.

In terms of distribution channel, the Europe acne medication market is segmented into pharmacies and drug stores, retail stores, and e-commerce. The pharmacies and drug stores segment held the largest share in 2022.

Based on country, the Europe acne medication market is categorized into Germany, France, the UK, Italy, Spain, and the Rest of Europe. Germany dominated the Europe acne medication market in 2022.

Sun Pharmaceutical Industries Ltd, Teva Pharmaceutical Industries Ltd, Almirall SA, Johnson & Johnson, Bausch Health Companies Inc, Galderma SA, Pfizer Inc, GSK Plc, Viatris Inc, and Pierre Fabre SA are some of the leading companies operating in the Europe acne medication market.

Product Code: BMIRE00030657

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Europe Acne Medication Market Landscape

4.1 PEST Analysis
4.2 Pricing Analysis of Topical and Oral Medication
4.3 Patient Population Undergoing Acne Treatment

5. Europe Acne Medication Market - Key Market Dynamics

5.1 Europe Acne Medication Market - Key Market Dynamics
5.2 Key Market Drivers
- 5.2.1 Increasing Prevalence of Severe Acne
- 5.2.2 Launch of Novel Drugs
5.3 Key Market Restraints
- 5.3.1 Side Effects Associated with Acne Medication
5.4 Key Market Opportunities
- 5.4.1 Individualized Treatment Programs Based on Cutting-Edge Technologies and Data-Driven Strategies
5.5 Future Trends
- 5.5.1 Upsurge in Need for Organic and Natural Treatments
5.6 Impact of Drivers and Restraints:

6. Acne Medication Market - Europe Market Analysis

7. Europe Acne Medication Market Analysis - by Therapeutic Class

7.1 Retinoids
- 7.1.1 Overview
- 7.1.2 Retinoids: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
7.2 Benzoyl Peroxide
- 7.2.1 Overview
- 7.2.2 Benzoyl Peroxide: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Antibiotics
- 7.3.1 Overview
- 7.3.2 Antibiotics: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Salicylic Acid
- 7.4.1 Overview
- 7.4.2 Salicylic Acid: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Others
- 7.5.1 Overview
- 7.5.2 Others: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Acne Medication Market Analysis - by Formulation

8.1 Topical Medication
- 8.1.1 Overview
- 8.1.2 Topical Medication: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
8.2 Oral Medication
- 8.2.1 Overview
- 8.2.2 Oral Medication: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Acne Medication Market Analysis - by Type

9.1 Prescription Medicine
- 9.1.1 Overview
- 9.1.2 Prescription Medicine: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
9.2 Over-the-Counter Medicine
- 9.2.1 Overview
- 9.2.2 Over-the-Counter Medicine: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Acne Medication Market Analysis - by Acne Type

10.1 Non-Inflammatory Acne
- 10.1.1 Overview
- 10.1.2 Non-Inflammatory Acne: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
10.2 Inflammatory Acne
- 10.2.1 Overview
- 10.2.2 Inflammatory Acne: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

11. Europe Acne Medication Market Analysis - by Distribution Channel

11.1 Pharmacies and Drug Stores
- 11.1.1 Overview
- 11.1.2 Pharmacies and Drug Stores: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
11.2 Retail Stores
- 11.2.1 Overview
- 11.2.2 Retail Stores: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
11.3 E-Commerce
- 11.3.1 Overview
- 11.3.2 E-Commerce: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

12. Europe Acne Medication Market - Country Analysis

12.1 Europe
- 12.1.1 Europe: Acne Medication Market - Revenue and Forecast Analysis - by Country
  - 12.1.1.1 Europe: Acne Medication Market - Revenue and Forecast Analysis - by Country
  - 12.1.1.2 Germany
  - 12.1.1.3 Germany: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.1.1.3.1 Germany: Acne Medication Market Breakdown, by Therapeutic Class
    - 12.1.1.3.2 Germany: Acne Medication Market Breakdown, by Formulation
    - 12.1.1.3.3 Germany: Acne Medication Market Breakdown, by Type
    - 12.1.1.3.4 Germany: Acne Medication Market Breakdown, by Acne Type
    - 12.1.1.3.5 Germany: Acne Medication Market Breakdown, by Distribution Channel
  - 12.1.1.4 France
  - 12.1.1.5 France: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.1.1.5.1 France: Acne Medication Market Breakdown, by Therapeutic Class
    - 12.1.1.5.2 France: Acne Medication Market Breakdown, by Formulation
    - 12.1.1.5.3 France: Acne Medication Market Breakdown, by Type
    - 12.1.1.5.4 France: Acne Medication Market Breakdown, by Acne Type
    - 12.1.1.5.5 France: Acne Medication Market Breakdown, by Distribution Channel
  - 12.1.1.6 UK
  - 12.1.1.7 UK: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.1.1.7.1 UK: Acne Medication Market Breakdown, by Therapeutic Class
    - 12.1.1.7.2 UK: Acne Medication Market Breakdown, by Formulation
    - 12.1.1.7.3 UK: Acne Medication Market Breakdown, by Type
    - 12.1.1.7.4 UK: Acne Medication Market Breakdown, by Acne Type
    - 12.1.1.7.5 UK: Acne Medication Market Breakdown, by Distribution Channel
  - 12.1.1.8 Italy
  - 12.1.1.9 Italy: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.1.1.9.1 Italy: Acne Medication Market Breakdown, by Therapeutic Class
    - 12.1.1.9.2 Italy: Acne Medication Market Breakdown, by Formulation
    - 12.1.1.9.3 Italy: Acne Medication Market Breakdown, by Type
    - 12.1.1.9.4 Italy: Acne Medication Market Breakdown, by Acne Type
    - 12.1.1.9.5 Italy: Acne Medication Market Breakdown, by Distribution Channel
  - 12.1.1.10 Spain
  - 12.1.1.11 Spain: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.1.1.11.1 Spain: Acne Medication Market Breakdown, by Therapeutic Class
    - 12.1.1.11.2 Spain: Acne Medication Market Breakdown, by Formulation
    - 12.1.1.11.3 Spain: Acne Medication Market Breakdown, by Type
    - 12.1.1.11.4 Spain: Acne Medication Market Breakdown, by Acne Type
    - 12.1.1.11.5 Spain: Acne Medication Market Breakdown, by Distribution Channel
  - 12.1.1.12 Rest of Europe
  - 12.1.1.13 Rest of Europe: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.1.1.13.1 Rest of Europe: Acne Medication Market Breakdown, by Therapeutic Class
    - 12.1.1.13.2 Rest of Europe: Acne Medication Market Breakdown, by Formulation
    - 12.1.1.13.3 Rest of Europe: Acne Medication Market Breakdown, by Type
    - 12.1.1.13.4 Rest of Europe: Acne Medication Market Breakdown, by Acne Type
    - 12.1.1.13.5 Rest of Europe: Acne Medication Market Breakdown, by Distribution Channel

13. Acne Medication Market- Industry Landscape

13.1 Overview
13.2 Growth Strategies in Acne Medication Market
13.3 Organic Growth Strategies
- 13.3.1 Overview
13.4 Inorganic Growth Strategies
- 13.4.1 Overview
13.5 Product Offered by Farmapiel vs Other Companies Acne Products

14. Company Profiles

14.1 Teva Pharmaceutical Industries Ltd
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Almirall SA
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Johnson & Johnson
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Sun Pharmaceutical Industries Ltd
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Bausch Health Companies Inc
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Galderma SA
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Pfizer Inc
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 GSK Plc
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 Viatris Inc
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 Pierre Fabre SA
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments

15. Appendix

15.1 About The Insight Partners
15.2 Glossary of Terms